Mirum Pharmaceuticals, Inc. MIRM Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s increase (decrease) in other operating assets?
- Mirum Pharmaceuticals, Inc. (MIRM) reported increase (decrease) in other operating assets of $4.8M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s increase (decrease) in other operating assets increased by 5113.0% year-over-year, from $92K to $4.8M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s increase (decrease) in other operating assets?
- Over 2 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s increase (decrease) in other operating assets has grown at a 230.3% compound annual growth rate (CAGR), from $519K to $5.66M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.